Cytek Biosciences, Inc.CTKBNASDAQ
Loading
Gross profit as a percentage of revenue
3Y CAGR
-5.6%/yr
Annual compound
5Y CAGR
-1.4%/yr
Recent deceleration
Percentile
P17
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
4 yr
Consecutive declineStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 51.84% | -6.5% |
| 2024 | 55.43% | -2.2% |
| 2023 | 56.69% | -7.9% |
| 2022 | 61.56% | -0.5% |
| 2021 | 61.86% | +11.1% |
| 2020 | 55.70% | +12.4% |
| 2019 | 49.54% | - |